PURPOSE: To assess whether perioperative allogenic blood transfusions in patients undergoing surgical treatment for spinal metastases independently influence patient survival. METHODS: A retrospective study including 170 consecutive patients undergoing surgical treatment for spinal metastases in 2009 and 2010 at a tertiary referral center. Variables related to postoperative survival were all included in the same multivariable logistic regression analysis with either 3- or 12-month survival as the dependent variable. The independent variables were: transfusion of allogenic red blood cells, age at surgery, gender, preoperative hemoglobin, revised Tokuhashi score and no. of instrumented levels. RESULTS: Perioperative allogenic blood transfusion of 1-2 units was associated with increased 12-month survival [p = 0.049, odds ratio 2.619 (confidence interval 1.004-6.831)], but not with 3-month survival. Larger transfusion volumes did not significantly influence survival. CONCLUSION: The results of the present study support that perioperative blood transfusion of <5 units does not decrease survival in patients operated for spinal metastases. Transfusion of 1-2 units seems to be associated with increased 12-month survival. Future studies should assess if a liberal transfusion regime can be applied to this group of patients; thereby, prioritizing early postoperative mobilization.
PURPOSE: To assess whether perioperative allogenic blood transfusions in patients undergoing surgical treatment for spinal metastases independently influence patient survival. METHODS: A retrospective study including 170 consecutive patients undergoing surgical treatment for spinal metastases in 2009 and 2010 at a tertiary referral center. Variables related to postoperative survival were all included in the same multivariable logistic regression analysis with either 3- or 12-month survival as the dependent variable. The independent variables were: transfusion of allogenic red blood cells, age at surgery, gender, preoperative hemoglobin, revised Tokuhashi score and no. of instrumented levels. RESULTS: Perioperative allogenic blood transfusion of 1-2 units was associated with increased 12-month survival [p = 0.049, odds ratio 2.619 (confidence interval 1.004-6.831)], but not with 3-month survival. Larger transfusion volumes did not significantly influence survival. CONCLUSION: The results of the present study support that perioperative blood transfusion of <5 units does not decrease survival in patients operated for spinal metastases. Transfusion of 1-2 units seems to be associated with increased 12-month survival. Future studies should assess if a liberal transfusion regime can be applied to this group of patients; thereby, prioritizing early postoperative mobilization.
Authors: G A Nuttall; T T Horlocker; P J Santrach; W C Oliver; M B Dekutoski; S Bryant Journal: Spine (Phila Pa 1976) Date: 2000-03-01 Impact factor: 3.468
Authors: Sohail K Mirza; Richard A Deyo; Patrick J Heagerty; Mark A Konodi; Lorri A Lee; Judith A Turner; Robert Goodkin Journal: Spine (Phila Pa 1976) Date: 2008-11-15 Impact factor: 3.468
Authors: Laurent G Glance; Andrew W Dick; Dana B Mukamel; Fergal J Fleming; Raymond A Zollo; Richard Wissler; Rabih Salloum; U Wayne Meredith; Turner M Osler Journal: Anesthesiology Date: 2011-02 Impact factor: 7.892
Authors: Alexis Falicov; Charles G Fisher; Joe Sparkes; Michael C Boyd; Peter C Wing; Marcel F Dvorak Journal: Spine (Phila Pa 1976) Date: 2006-11-15 Impact factor: 3.468
Authors: Stein J Janssen; Yvonne Braun; John E Ready; Kevin A Raskin; Marco L Ferrone; Francis J Hornicek; Joseph H Schwab Journal: Clin Orthop Relat Res Date: 2015-01-31 Impact factor: 4.176
Authors: Awais K Hussain; Zoe B Cheung; Khushdeep S Vig; Kevin Phan; Mauricio C Lima; Jun S Kim; John Di Capua; Deepak A Kaji; Varun Arvind; Samuel K Cho Journal: Global Spine J Date: 2018-08-26
Authors: Collin W Blackburn; Katherine L Morrow; Joseph E Tanenbaum; Jessica E DeCaro; Judith M Gron; Michael P Steinmetz Journal: Global Spine J Date: 2018-10-11